SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-022556
Filing Date
2019-11-08
Accepted
2019-11-08 16:05:07
Documents
57
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0919_inmunebioinc.htm 10-Q 459894
2 CERTIFICATION f10q0919ex31-1_inmunebioinc.htm EX-31.1 10097
3 CERTIFICATION f10q0919ex31-2_inmunebioinc.htm EX-31.2 10029
4 CERTIFICATION f10q0919ex32-1_inmunebioinc.htm EX-32.1 4201
5 CERTIFICATION f10q0919ex32-2_inmunebioinc.htm EX-32.2 4152
6 GRAPHIC image_001.jpg GRAPHIC 137361
7 GRAPHIC image_002.jpg GRAPHIC 204948
8 GRAPHIC image_003.jpg GRAPHIC 175897
9 GRAPHIC image_004.jpg GRAPHIC 226091
  Complete submission text file 0001213900-19-022556.txt   3819450

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE FILE inmb-20190930.xml EX-101.INS 383536
11 XBRL SCHEMA FILE inmb-20190930.xsd EX-101.SCH 39095
12 XBRL CALCULATION FILE inmb-20190930_cal.xml EX-101.CAL 40537
13 XBRL DEFINITION FILE inmb-20190930_def.xml EX-101.DEF 150136
14 XBRL LABEL FILE inmb-20190930_lab.xml EX-101.LAB 284750
15 XBRL PRESENTATION FILE inmb-20190930_pre.xml EX-101.PRE 226965
Mailing Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037
Business Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38793 | Film No.: 191204055
SIC: 2836 Biological Products, (No Diagnostic Substances)